• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Fatal clinical course of probable invasive pulmonary aspergillosis with influenza B infection in an immunocompetent patient

tetano

Editor, Senior Moderator
Tuberc Respir Dis (Seoul). 2014 Sep;77(3):141-4. doi: 10.4046/trd.2014.77.3.141. Epub 2014 Sep 30.
Fatal clinical course of probable invasive pulmonary aspergillosis with influenza B infection in an immunocompetent patient.
Park DW, Yhi JY, Koo G, Jung SJ, Kwak HJ, Moon JY, Kim SH, Kim TH, Sohn JW, Shin DH, Park SS, Yoon HJ.
Author information
Abstract

Invasive pulmonary aspergillosis (IPA) is rarely reported in patients who have normal immune function. Recently, IPA risk was reported in nonimmunocompromised hosts, such as patients with chronic obstructive pulmonary disease and critically ill patients in intensive care units. Moreover, influenza infection is also believed to be associated with IPA among immunocompetent patients. However, most reports on IPA with influenza A infection, including pandemic influenza H1N1, and IPA associated with influenza B infection were scarcely reported. Here, we report probable IPA with a fatal clinical course in an immunocompetent patient with influenza B infection. We demonstrate IPA as a possible complication in immunocompetent patients with influenza B infection. Early clinical suspicion of IPA and timely antifungal therapy are required for better outcomes in such cases.
KEYWORDS:

Immunocompetence; Influenza B Virus; Invasive Pulmonary Aspergillosis

PMID:
25309610
[PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/25309610
 
Back
Top Bottom